IDYA - CIK 0001676725
IDEAYA Biosciences, Inc. (IDYA) reported revenue of $218.71M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $218.71M | +3024.4% |
| FY 2024 | $7.00M | -70.1% |
| FY 2023 | $23.39M | -54.1% |
| FY 2022 | $50.93M | +82.3% |
| FY 2021 | $27.94M | +43.0% |
| FY 2020 | $19.54M | - |
| FY 2019 | $0.00 | - |
IDEAYA Biosciences, Inc. (IDYA) reported revenue of $218.71M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, IDEAYA Biosciences, Inc.'s revenue grew from $0.00 to $218.71M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.